Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma

Modern Pathology

Volumn 23, Issue 3, 2010, Pages 404-412

  Pinto, Alvaro P ^a,c   Miron, Alexander ^b   Yassin, Yosuf ^b   Monte, Nicolas ^c   Woo, Terri Y C ^c   Mehra, Karishma K ^c   Medeiros, Fabiola ^d   Crum, Christopher P ^c  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Differentiated vulvar intraepithelial neoplasia; P63; Tp53; Vulvar carcinoma

Indexed keywords

PROTEIN P53; PROTEIN P63;

ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; PATHOGENESIS; PRIORITY JOURNAL; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; TP53 GENE; TUMOR SUPPRESSOR GENE; VULVA CARCINOMA; VULVA TUMOR; WART VIRUS;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MICRODISSECTION; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; TUMOR SUPPRESSOR PROTEIN P53; VULVAR NEOPLASMS;

EID: 77649270419     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.179     Document Type: Article

References (25)

1. Petitjean A, Mathe E, Kato S, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007;28:622-629.
2. Crum CP, McLachlin CM, Tate JE, et al. Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynecol 1997;9:63-69.
3. Münger K, Scheffner M, Huibregtse JM, et al. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surv 1992;12: 197-217.
4. Sano T, Oyama T, Kashiwabara K, et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153:1741-1748.
5. Riethdorf S, Neffen EF, Cviko A, et al. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol 2004;35:1477-1483.
6. Neill SM, Lessana-Leibowitch M, Pelisse M, et al. Lichen sclerosus, invasive squamous cell carcinoma, and human papillomavirus. Am J Obstet Gynecol 1990;162:1633-1634.
7. Soufir N, Queille S, Liboutet M, et al. Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors. Br J Dermatol 2007;156:448-453.
8. Rolfe KJ, MacLean AB, Crow JC, et al. TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. Br J Cancer 2003;89: 2249-2253.
9. Hietanen SH, Kurvinen K, Syrjänen K, et al. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Am J Obstet Gynecol 1995;173:1477-1482.
10. McCluggage WG. Recent developments in vulvovagi-nal pathology. Histopathology 2009;54:156-173.
11. Ordi J, Alejo M, Fusté V, et al. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histolo-gic pattern: an unrecognized variant of simplex (differentiated) VIN. Am J Surg Pathol 2009;33: 1659-1665.
12. Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol 2000;24:429-441.
13. Lin MC, Mutter GL, Trivijisilp P, et al. Patterns of allelic loss (LOH) in vulvar squamous carcinomas and adjacent noninvasive epithelia. Am J Pathol 1998; 152:1313-1318.
14. Pinto AP, Lin MC, Mutter GL, et al. Allelic loss in human papillomavirus-positive and-negative vulvar squamous cell carcinomas. Am J Pathol 1999;154: 1009-1015.
15. Pinto AP, Lin MC, Sheets EE, et al. Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neo-plasia of the vulva. Gynecol Oncol 2000;770:171-176.
16. Senoo M, Pinto F, Crum CP, et al. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007;129:523-536.
17. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714-718.
18. Tate JE, Yang Y-C, Shen J, et al. A comparison of early (E7) and late (L1) primer-mediated amplification of papillomaviral DNA in cervical neoplasia. Mol Cell Probes 1996;10:347-351.
19. Williams C, Pontén F, Moberg C, et al. A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol 1999;155:1467-1471.
20. Vanin K, Scurry J, Thorne H, et al. Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer. J Invest Der-matol 2002;119:1027-1033.
21. Liegl B, Regauer S. p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neopla-sia (d-VIN). Histopathology 2006;48:268-274.
22. Rosenthal AN, Hopster D, Ryan A, et al. Immunohis-tochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma. Br J Cancer 2003;88:251-256.
23. Chiesa-Vottero A, Dvoretsky PM, Hart WR. Histopatho-logic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol 2006;30:310-318.
24. Roma AA, Hart WR. Progression of simplex (differentiated) vulvar intraepithelial neoplasia to invasive squamous cell carcinoma: a prospective case study confirming its precursor role in the pathogenesis of vulvar cancer. Int J Gynecol Pathol 2007;26:248-253.
25. Quade BJ, Yang A, Wang Y, et al. Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 2001;80:24-29.